Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Anna C Bibby"'
Autor:
Kevin G Blyth, Nick A Maskell, Louise Stadon, John E Harvey, Anna C Bibby, Charles Comins, Ruairi J H Conway, Jenny Symonds, Deborah Walton, Janet Probets
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Introduction Mesothelioma is a heterogeneous disease that can be challenging to monitor and prognosticate. ASSESS-meso is a multicentre, prospective, longitudinal observational cohort study of patients with mesothelioma. The primary aim is to describ
Externí odkaz:
https://doaj.org/article/fed3c23ef8714be98eb3eaad49a1b60c
Autor:
Ruairi J.H. Conway, Natalie Smith, William Cooper, Geraldine Lynch, Sonia Patole, Jenny Symonds, Anthony Edey, Nick A. Maskell, Anna C. Bibby, on behalf of the ASSESS-meso Collaborative group, Natalie Zahan-Evans
Publikováno v:
ERJ Open Research, Vol 9, Iss 6 (2023)
Objective Mesothelioma varies in clinical phenotype and survival. Clinical trials are unavoidably affected by selection bias, reducing generalisability. ASSESS-meso is a UK, multicentre, prospective, mesothelioma cohort study (ISRCTN61861764). This p
Externí odkaz:
https://doaj.org/article/8f09a3902b52420cb7bb95a887ee02f8
Autor:
Anna C. Bibby, Natalie Zahan-Evans, Emma Keenan, Charles Comins, John E. Harvey, Helen Day, Najib M. Rahman, Janet E. Fallon, Rachael Gooberman-Hill, Nick A. Maskell
Publikováno v:
Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Background Malignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy with a poor prognosis. Systemic immunotherapy is an effective frontline treatment for MPM, and there is a scientific rationale supporting the possible effic
Externí odkaz:
https://doaj.org/article/46850c2933a64806a22650fc5c093064
Autor:
Duneesha De Fonseka, David T. Arnold, Anna J. Morley, Mary Brett, Nidhi Bhatt, Anthony Edey, Richard Daly, Anna C. Bibby, Nick A. Maskell
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background As promising novel treatments develop for malignant pleural mesothelioma (MPM), early prognostication has become increasingly important. Circulating and local inflammatory cells are known to play a significant role in other tumour
Externí odkaz:
https://doaj.org/article/156c695976ce4ed8a37b5cf5fb703eef
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-6 (2018)
Abstract Background The ‘trials within cohorts’ (TwiC) design is a pragmatic approach to randomised trials in which trial participants are randomly selected from an existing cohort. The design has multiple potential benefits, including the option
Externí odkaz:
https://doaj.org/article/e1bf4d65df504aabbdc09ea9d784c1fb
Autor:
Anna C. Bibby, Duneesha De Fonseka, Anna J. Morley, Emma Keenan, Alfredo Addeo, Sarah Smith, Anthony J. Edey, Nick A. Maskell
Publikováno v:
BMC Palliative Care, Vol 16, Iss 1, Pp 1-7 (2017)
Abstract Background Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, o
Externí odkaz:
https://doaj.org/article/95d23a2a164341548ba0dc592eae070c
Autor:
Anna C. Bibby, Selina Tsim, Nikolaos Kanellakis, Hannah Ball, Denis C. Talbot, Kevin G. Blyth, Nick A. Maskell, Ioannis Psallidas
Publikováno v:
European Respiratory Review, Vol 25, Iss 142, Pp 472-486 (2016)
Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in th
Externí odkaz:
https://doaj.org/article/6a422b200a0344e3b029b8645bffa6dd
Publikováno v:
Chest. 160:1915-1924
Background Malignant pleural effusions (MPEs) often cause symptoms, and guidelines recommend early definitive intervention. However, observational data suggest that systemic anticancer treatment (SACT) may control MPE because of certain pharmacologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dba6ff46078806a813b9ade1f40bf4c
https://doi.org/10.1016/j.chest.2021.05.027
https://doi.org/10.1016/j.chest.2021.05.027
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 11 (2017)
Malignant pleural effusions (MPEs) are an important cause of cancer-related mortality and morbidity. It is a heterogeneous group of conditions, which leads to debilitating symptoms and confers a poor prognosis. Recent well-designed randomized trials
Externí odkaz:
https://doaj.org/article/873885f882a94dba925d98025bcbc0c1
Autor:
Anna C. Bibby, Nick A Maskell
Chylous effusions are caused by the accumulation of chlye in the thoracic cavity (also known as chylothorax). Chyle is a protein—and calorie—rich fluid with nutritional and immunological functions. It is transported around the body via the lympha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23cd558dc87b37b3e38d65b04cd33f64
https://doi.org/10.1016/b978-0-12-801238-3.11416-3
https://doi.org/10.1016/b978-0-12-801238-3.11416-3
